ALEXION PHARMACEUTICALS
Alexion Pharmaceuticals is a biopharmaceutical company, which is engaged in the discovery, development, and commercialization of biologic therapeutic products aimed at treating patients with severe and life-threatening disease states, including hematologic, kidney and neurologic diseases, transplant rejection, cancer, and autoimmune disorders. Its marketed product Soliris (eculizumab) is a therapy approved for the treatment of patients with paroxysmal nocturnal hemoglobinuria (PNH). In April 2... 009 and August 2009, the United States food and drug administration (FDA) and the European Commission (E.C.), respectively, granted Soliris orphan drug designation for the treatment of patients with atypical Hemolytic Uremic Syndrome (aHUS). In December 2009, its Rhode Island manufacturing facility received regulatory approval from the E.C. Or the production of Soliris.
ALEXION PHARMACEUTICALS
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
1992-01-01
Address:
Cheshire, Connecticut, United States
Country:
United States
Website Url:
http://www.alexion.com
Total Employee:
1001+
Status:
Active
Contact:
(203) 272-2596
Email Addresses:
[email protected]
Total Funding:
5.8 M USD
Technology used in webpage:
LetsEncrypt WordPress Domain Not Resolving Apache Wordpress Plugins Nginx Sitelinks Search Box IPv6 Yoast WordPress SEO Plugin Yoast SEO Premium
Similar Organizations
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization.
AVEO Oncology
AVEO is a biopharmaceutical company that offers drug development strategies for targeted cancer therapeutics.
BioAxone Therapeutic
BioAxone Therapeutic is neuroscience company focused on the development and commercialization of technologies that target Rho signaling.
BoneCare International
Bone Care International, Inc., a pharmaceutical company, engages in the discovery, development, and commercialization.
Connetics
Connetics Corporation engages in the development and commercialization of products for the medical dermatology market.
Mallinckrodt
Their evolution as a company starts now, and they are poised for an exciting future. Their core strengths provide the impetus for future
Merck
Merck is a biopharmaceutical company that offers medicines and vaccines for various diseases.
Merz Pharma
Merz Pharmaceuticals is an innovative pharmaceutical company specializing in the research and marketing of drugs for the treatment of
Pivot Pharmaceuticals
Pivot Pharmaceuticals is a biopharmaceutical company engaged in the development and commercialization of therapeutic pharmaceuticals.
PTC Therapeutics
PTC Therapeutics is a biopharmaceutical company that engages in the discovery, development and commercialization of small-molecule drugs.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Teva Pharmaceutical Industries
Teva Pharmaceutical Industries is a pharmaceutical company specializing in the development, production and marketing of generic.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2020-05-05 | Portola Pharmaceuticals | Portola Pharmaceuticals acquired by Alexion Pharmaceuticals | 1.4 B USD |
| 2019-10-16 | Achillion Pharmaceuticals | Achillion Pharmaceuticals acquired by Alexion Pharmaceuticals | N/A |
| 2018-09-26 | Syntimmune | Syntimmune acquired by Alexion Pharmaceuticals | 1.2 B USD |
| 2018-04-11 | Wilson Therapeutics | Wilson Therapeutics acquired by Alexion Pharmaceuticals | N/A |
| 2015-05-06 | Synageva BioPharma | Synageva BioPharma acquired by Alexion Pharmaceuticals | 8.4 B USD |
| 2011-12-29 | Enobia Pharma | Enobia Pharma acquired by Alexion Pharmaceuticals | N/A |
| 2011-01-31 | Taligen Therapeutics | Taligen Therapeutics acquired by Alexion Pharmaceuticals | 111 M USD |
| 2000-09-25 | Prolifaron | Prolifaron acquired by Alexion Pharmaceuticals | 41 M USD |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2015-01-05 | Moderna Therapeutics | Alexion Pharmaceuticals investment in Series E - Moderna Therapeutics | 450 M USD |
| 2014-01-14 | Moderna Therapeutics | Alexion Pharmaceuticals investment in Corporate Round - Moderna Therapeutics | 25 M USD |
Key Employee Changes
| Date | New article |
|---|---|
| 2020-08-06 | Alexion hires first chief diversity officer, following pharma peers and social sentiment |
| 2020-02-04 | Amylyx Pharmaceuticals Appoints Jeffrey Trigilio Chief Financial Officer |
Official Site Inspections
http://www.alexion.com Semrush global rank: 1.18 M Semrush visits lastest month: 26.52 K
- Host name: server-18-67-65-111.iad89.r.cloudfront.net
- IP address: 18.67.65.111
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
